Literature DB >> 18263590

Interaction between ERK and GSK3beta mediates basic fibroblast growth factor-induced apoptosis in SK-N-MC neuroblastoma cells.

Cuiling Ma1, Kimberly A Bower, Gang Chen, Xianglin Shi, Zun-Ji Ke, Jia Luo.   

Abstract

The Ewing's sarcoma family of tumors (ESFT) includes Ewing's sarcoma (ES), Askin's tumor of the chest wall, and peripheral primitive neuroectodermal tumor. Basic fibroblast growth factor (FGF2) suppresses the growth of ESFT cells and causes their apoptosis. The underlying mechanism is unclear. Using a human peripheral primitive neuroectodermal tumor cell line, SK-N-MC, we demonstrated FGF2 stimulated phosphorylation of ERK1 and ERK2 (pERK1/2) and GSK3beta (pGSK3beta(Tyr-216)), all of which were primarily retained in the cytoplasm. FGF2 promoted the association between ERK and pGSK3beta(Tyr-216). Inhibitors for GSK3beta (TDZD and LiCl) and ERK (PD98059) protected cells from FGF2-induced apoptosis. On the other hand, inhibitors of GSK3beta, but not PD98059 decreased ERK/pGSK3beta(Tyr-216) association and caused a nuclear translocation of pERK1/2. Similarly, expression of a kinase-deficient (K85R) GSK3beta or GSK3beta-small interfering RNA inhibited FGF2-regulated ERK/pGSK3beta(Tyr-216) association and translocated pERK to the nucleus. Both K85R GSK3beta and small interfering RNA offered protection against FGF2-induced cell death. In contrast, overexpression of wild-type GSK3beta sensitized cells to FGF2 cytotoxicity. Hydrogen peroxide and ethanol enhanced FGF2-stimulated pGSK3beta(Tyr-216), ERK/pGSK3beta(Tyr-216) association, and cytoplasmic retention of pERK1/2. As a result, they potentiated FGF2-induced cell death. Taken together, our results suggested that FGF2-induced accumulation of pERK1/2 in the cytoplasm is toxic for SK-N-MC cells. The formation of an ERK.GSK3beta complex retained pERK1/2 in the cytoplasm. In contrast, disruption of the ERK.GSK3beta complex resulted in nuclear translocation of pERK1/2 and offered protection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18263590      PMCID: PMC2431019          DOI: 10.1074/jbc.M707316200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.

Authors:  I Ferrer; R Blanco; M Carmona; R Ribera; E Goutan; B Puig; M J Rey; A Cardozo; F Viñals; T Ribalta
Journal:  Brain Pathol       Date:  2001-04       Impact factor: 6.508

Review 2.  Expanding roles for beta-arrestins as scaffolds and adapters in GPCR signaling and trafficking.

Authors:  W E Miller; R J Lefkowitz
Journal:  Curr Opin Cell Biol       Date:  2001-04       Impact factor: 8.382

3.  Cytoplasmic aggregates of phosphorylated extracellular signal-regulated protein kinases in Lewy body diseases.

Authors:  Jian-Hui Zhu; Scott M Kulich; Tim D Oury; Charleen T Chu
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

4.  The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation.

Authors:  Akira Tohgo; Eric W Choy; Diane Gesty-Palmer; Kristen L Pierce; Stephane Laporte; Robert H Oakley; Marc G Caron; Robert J Lefkowitz; Louis M Luttrell
Journal:  J Biol Chem       Date:  2002-12-06       Impact factor: 5.157

Review 5.  The role of basic fibroblast growth factor in peripheral nerve regeneration.

Authors:  C Grothe; G Nikkhah
Journal:  Anat Embryol (Berl)       Date:  2001-09

6.  Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.

Authors:  I Ferrer; R Blanco; M Carmona; B Puig
Journal:  J Neural Transm (Vienna)       Date:  2001       Impact factor: 3.575

7.  Transient increases in intracellular calcium result in prolonged site-selective increases in Tau phosphorylation through a glycogen synthase kinase 3beta-dependent pathway.

Authors:  J A Hartigan; G V Johnson
Journal:  J Biol Chem       Date:  1999-07-23       Impact factor: 5.157

Review 8.  Mechanism of basic fibroblast growth factor-induced cell death.

Authors:  S A Burchill; G Westwood
Journal:  Apoptosis       Date:  2002-02       Impact factor: 4.677

9.  Protein kinase C-alpha and ERK1/2 mediate mitochondrial dysfunction, decreases in active Na+ transport, and cisplatin-induced apoptosis in renal cells.

Authors:  Grazyna Nowak
Journal:  J Biol Chem       Date:  2002-09-05       Impact factor: 5.157

10.  STAT1 mediates the increased apoptosis and reduced chondrocyte proliferation in mice overexpressing FGF2.

Authors:  M Sahni; R Raz; J D Coffin; D Levy; C Basilico
Journal:  Development       Date:  2001-06       Impact factor: 6.868

View more
  13 in total

Review 1.  Protease-activated receptor 4: a critical participator in inflammatory response.

Authors:  Qiang Fu; Jing Cheng; Yebo Gao; Yonglei Zhang; Xiaobing Chen; Jianguo Xie
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

2.  The CDK4/6 inhibitor palbociclib synergizes with irinotecan to promote colorectal cancer cell death under hypoxia.

Authors:  Jun Zhang; Lanlan Zhou; Shuai Zhao; David T Dicker; Wafik S El-Deiry
Journal:  Cell Cycle       Date:  2017-05-09       Impact factor: 4.534

3.  Suppression of GSK-3β activation by M-cadherin protects myoblasts against mitochondria-associated apoptosis during myogenic differentiation.

Authors:  Yan Wang; Yanlei Hao; Stephen E Alway
Journal:  J Cell Sci       Date:  2011-11-23       Impact factor: 5.285

4.  Induction of Id-1 by FGF-2 involves activity of EGR-1 and sensitizes neuroblastoma cells to cell death.

Authors:  Giovanni Passiatore; Antonio Gentilella; Slava Rom; Marco Pacifici; Valeria Bergonzini; Francesca Peruzzi
Journal:  J Cell Physiol       Date:  2011-07       Impact factor: 6.384

5.  Inhibition of glioblastoma growth by the thiadiazolidinone compound TDZD-8.

Authors:  Diana Aguilar-Morante; Jose Angel Morales-Garcia; Marina Sanz-SanCristobal; Miguel Angel Garcia-Cabezas; Angel Santos; Ana Perez-Castillo
Journal:  PLoS One       Date:  2010-11-08       Impact factor: 3.240

6.  Overexpression of glycogen synthase kinase 3beta sensitizes neuronal cells to ethanol toxicity.

Authors:  Ying Liu; Gang Chen; Cuiling Ma; Kimberly A Bower; Mei Xu; Zhiqin Fan; Xianglin Shi; Zun-Ji Ke; Jia Luo
Journal:  J Neurosci Res       Date:  2009-09       Impact factor: 4.164

7.  Reactive oxygen species induce MMP12-dependent degradation of collagen 5 and fibronectin to promote the motility of human umbilical cord-derived mesenchymal stem cells.

Authors:  Seung Pil Yun; Sei-Jung Lee; Sang Yub Oh; Young Hyun Jung; Jung Min Ryu; Han Na Suh; Mi Ok Kim; Keon Bong Oh; Ho Jae Han
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

8.  N-(4-Hydroxyphenyl) Retinamide Potentiated Anti-tumor Efficacy of Genistein in Human Ewing's Sarcoma Xenografts.

Authors:  Surajit Karmakar; Subhasree Roy Choudhury; Naren L Banik; Swapan K Ray
Journal:  World J Oncol       Date:  2011-04

9.  Role of the ERK pathway for oxidant-induced parthanatos in human lymphocytes.

Authors:  Ali A Akhiani; Olle Werlenius; Johan Aurelius; Charlotta Movitz; Anna Martner; Kristoffer Hellstrand; Fredrik B Thorén
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

10.  EWS Knockdown and Taxifolin Treatment Induced Differentiation and Removed DNA Methylation from p53 Promoter to Promote Expression of Puma and Noxa for Apoptosis in Ewing's Sarcoma.

Authors:  Mohammad Motarab Hossain; Swapan Kumar Ray
Journal:  J Cancer Ther       Date:  2014-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.